A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies.
Slovak ML, Gundacker H, Bloomfield CD, Dewald G, Appelbaum FR, Larson RA, Tallman MS, Bennett JM, Stirewalt DL, Meshinchi S, Willman CL, Ravindranath Y, Alonzo TA, Carroll AJ, Raimondi SC, Heerema NA.
Slovak ML, et al. Among authors: meshinchi s.
Leukemia. 2006 Jul;20(7):1295-7. doi: 10.1038/sj.leu.2404233. Epub 2006 Apr 20.
Leukemia. 2006.
PMID: 16628187
No abstract available.